Elicio Therapeutics
Lymph-Node Targeted Immunotherapies
47 employees · est. 2011 · Boston, United States
Mural Oncology
Leveraging our protein engineering platform to improve cytokine-based immunotherapies for the treatment of #cancer
112 employees · est. 2023 · Waltham, United States
Elicio Therapeutics is the older company (2011 vs 2023); Mural Oncology is the larger of the two.
Side-by-Side Comparison
| Metric | Elicio Therapeutics | Mural Oncology |
|---|---|---|
| Founded | ||
| Founded | 2011 older | 2023 |
| Headquarters | ||
| Headquarters | Boston, United States | Waltham, United States |
| Employees | ||
| Employees | 47 | 112 larger |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | IPO | Corporate Round |
| Total Funding | ||
| Total Funding | $206.86M | $275.00M |
| Funding Rounds | ||
| Funding Rounds | 17 | 1 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Immunotherapy, Cancer Treatment, Vaccine Development, Immune Response Modulation, Lymphatic System Targeting, Amphiphile Platform, Precision Medicine, Oncology Research, Biological Engineering, Materials Science, Drug Development, Preclinical Studies, Immune System Enhancement, Cellular Immunology, Biomedical Technology | Immuno-oncology, Cytokine Biology, Cancer, Drug Discovery, Protein Engineering, Immunotherapy, Ovarian Cancer, Melanoma, Nemvaleukin Alfa, Interleukin-18, Interleukin-12, Immune Cell Modulation, Tumor-targeted Therapies, Public Company, Clinical Benefit |
| Website | ||
| Website | elicio.com | muraloncology.com |
About Elicio Therapeutics
Elicio Therapeutics, Inc. (Nasdaq: ELTX) is a clinical-stage biotechnology company founded in 2011, with a focus on advancing a pipeline of novel lymph node-targeted immunotherapies for the treatment of aggressive cancers. The company's slogan "Orchestrating the immune response to defeat cancer & in...
About Mural Oncology
Mural Oncology, founded in 2023, is a healthcare startup based in the United States. The company focuses on leveraging its protein engineering platform to revolutionize cytokine-based immunotherapies for the treatment of cancer. Their slogan, "Leveraging our protein engineering platform to improve c...
We will tell you when either one moves
BounceWatch watches Elicio Therapeutics and Mural Oncology for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Elicio Therapeutics and Mural Oncology — by email.
Frequently Asked Questions
Compare Elicio Therapeutics with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Elicio Therapeutics on 9 Jun 2026, and Mural Oncology on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.